<DOC>
	<DOCNO>NCT01847664</DOCNO>
	<brief_summary>The purpose trial compare efficacy Rifamycin SV-MMX速 400 mg b.i.d . vs. Rifamycin SV-MMX速 600 mg t.i.d . vs. placebo patient acute uncomplicated diverticulitis .</brief_summary>
	<brief_title>Rifamycin SV-MMX速 400 mg b.i.d . vs. Rifamycin SV-MMX速 600 mg t.i.d . v . Placebo Acute Uncomplicated Diverticulitis</brief_title>
	<detailed_description />
	<mesh_term>Diverticulitis</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<mesh_term>Rifamycin SV</mesh_term>
	<criteria>1 . Signed informed consent , 2 . Patient eligible outpatient treatment , 3 . Men woman 18 80 year age , 4 . Diagnosis leftsided uncomplicated diverticulitis confirm ultrasonography ( US ) and/or compute tomography ( CT ) accord modify Hinchey classification ( stage 1a ) Hansen/Stock classification ( stage I/IIa ) Ambrosetti classification ( stage mild ) , 5 . Presence significant leave low quadrant pain last 24 hour baseline , 6 . CRP &gt; ULN and/or leucocytosis ( &gt; ULN ) screen visit 1 . Existing complication diverticulitis ( diverticulitis associate abscess , fistula , obstruction perforation ) , 2 . Rightsided diverticulitis , 3 . Previous colonic surgery ( except appendectomy , haemorrhoidectomy , endoscopic removal polyp ) , 4 . Chronic inflammatory bowel disease ( Crohn ` disease , ulcerative colitis ) celiac disease , 5 . Presence symptomatic organic disease gastrointestinal tract ( exception nonbleeding hemorrhoid hiatal hernia ) , 6 . Hemorrhagic diathesis , 7 . Active peptic ulcer disease , 8 . Abnormal hepatic function liver cirrhosis , 9 . Abnormal renal function , 10 . Colorectal cancer history colorectal cancer ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>